Product
Viloxazine
1 clinical trial
1 indication
Indication
Attention-Deficit/Hyperactivity DisorderClinical trial
A Phase I/IIa Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Immediate-Release Viloxazine in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)Status: Completed, Estimated PCD: 2010-12-01